442 related articles for article (PubMed ID: 29326266)
1. The epigenetic control of stemness in CD8
Pace L; Goudot C; Zueva E; Gueguen P; Burgdorf N; Waterfall JJ; Quivy JP; Almouzni G; Amigorena S
Science; 2018 Jan; 359(6372):177-186. PubMed ID: 29326266
[TBL] [Abstract][Full Text] [Related]
2. ThPOK represses CXXC5, which induces methylation of histone H3 lysine 9 in Cd40lg promoter by association with SUV39H1: implications in repression of CD40L expression in CD8+ cytotoxic T cells.
Tsuchiya Y; Naito T; Tenno M; Maruyama M; Koseki H; Taniuchi I; Naoe Y
J Leukoc Biol; 2016 Aug; 100(2):327-38. PubMed ID: 26896487
[TBL] [Abstract][Full Text] [Related]
3. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
[TBL] [Abstract][Full Text] [Related]
4. ATF7ip Targets Transposable Elements for H3K9me3 Deposition to Modify CD8
Sin JH; Kashyap S; Acenas D; Cortez JT; Lee J; Marson A; Matloubian M; Waterfield MR
J Immunol; 2022 Mar; 208(5):1155-1169. PubMed ID: 35110421
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
[TBL] [Abstract][Full Text] [Related]
6. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
[TBL] [Abstract][Full Text] [Related]
7. An epigenetic silencing pathway controlling T helper 2 cell lineage commitment.
Allan RS; Zueva E; Cammas F; Schreiber HA; Masson V; Belz GT; Roche D; Maison C; Quivy JP; Almouzni G; Amigorena S
Nature; 2012 Jul; 487(7406):249-53. PubMed ID: 22763435
[TBL] [Abstract][Full Text] [Related]
8. Polycomb Repressive Complex 2-Mediated Chromatin Repression Guides Effector CD8
Gray SM; Amezquita RA; Guan T; Kleinstein SH; Kaech SM
Immunity; 2017 Apr; 46(4):596-608. PubMed ID: 28410989
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
[TBL] [Abstract][Full Text] [Related]
10. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
11. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain.
Davison JM; Mellott TJ; Kovacheva VP; Blusztajn JK
J Biol Chem; 2009 Jan; 284(4):1982-9. PubMed ID: 19001366
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of surfactant protein A gene (SP-A) expression in fetal lung reveals a critical role for Suv39h methyltransferases during development and hypoxia.
Benlhabib H; Mendelson CR
Mol Cell Biol; 2011 May; 31(10):1949-58. PubMed ID: 21402781
[TBL] [Abstract][Full Text] [Related]
13. Effector CD8 T cells dedifferentiate into long-lived memory cells.
Youngblood B; Hale JS; Kissick HT; Ahn E; Xu X; Wieland A; Araki K; West EE; Ghoneim HE; Fan Y; Dogra P; Davis CW; Konieczny BT; Antia R; Cheng X; Ahmed R
Nature; 2017 Dec; 552(7685):404-409. PubMed ID: 29236683
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
[TBL] [Abstract][Full Text] [Related]
15. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
Spensberger D; Delwel R
FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
[TBL] [Abstract][Full Text] [Related]
16. Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells.
Bandyopadhyay S; Montagna C; Macian F
Eur J Immunol; 2012 Sep; 42(9):2471-83. PubMed ID: 22684523
[TBL] [Abstract][Full Text] [Related]
17. Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.
Mal AK
EMBO J; 2006 Jul; 25(14):3323-34. PubMed ID: 16858404
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infection.
Mamonkin M; Puppi M; Lacorazza HD
Eur J Immunol; 2014 Mar; 44(3):715-27. PubMed ID: 24338897
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes.
Villeneuve LM; Reddy MA; Lanting LL; Wang M; Meng L; Natarajan R
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9047-52. PubMed ID: 18579779
[TBL] [Abstract][Full Text] [Related]
20. The Notch signaling pathway controls short-lived effector CD8+ T cell differentiation but is dispensable for memory generation.
Mathieu M; Duval F; Daudelin JF; Labrecque N
J Immunol; 2015 Jun; 194(12):5654-62. PubMed ID: 25972473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
